Advancements in Canadian Biomaterials Research in Neurotraumatic Diagnosis and Therapies

Development of biomaterials for the diagnosis and treatment of neurotraumatic ailments has been significantly advanced with our deepened knowledge of the pathophysiology of neurotrauma. Canadian research in the fields of biomaterial-based contrast agents, non-invasive axonal tracing, non-invasive sc...

Full description

Bibliographic Details
Main Authors: Suzan Chen, Angela M. Auriat, Tongda Li, Taisa R. Stumpf, Ryan Wylie, Xiongbiao Chen, Stephanie M. Willerth, Maria DeRosa, Maryam Tarizian, Xudong Cao, Eve C. Tsai
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Processes
Subjects:
Online Access:https://www.mdpi.com/2227-9717/7/6/336
Description
Summary:Development of biomaterials for the diagnosis and treatment of neurotraumatic ailments has been significantly advanced with our deepened knowledge of the pathophysiology of neurotrauma. Canadian research in the fields of biomaterial-based contrast agents, non-invasive axonal tracing, non-invasive scaffold imaging, scaffold patterning, 3D printed scaffolds, and drug delivery are conquering barriers to patient diagnosis and treatment for traumatic injuries to the nervous system. This review highlights some of the highly interdisciplinary Canadian research in biomaterials with a focus on neurotrauma applications.
ISSN:2227-9717